These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8852296)

  • 1. Test methods for predicting tardive toxicity of therapeutic drugs using laboratory animals.
    Ando K
    J Toxicol Sci; 1996 Feb; 21(1):105-7. PubMed ID: 8852296
    [No Abstract]   [Full Text] [Related]  

  • 2. Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam.
    Yamamoto N; Oda T; Inada T
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):691-4. PubMed ID: 18081635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobiochemical changes in tardive dyskinesia.
    Gunne LM; Häggström JE; Johansson P; Levin ED; Terenius L
    Encephale; 1988 Sep; 14 Spec No():167-73. PubMed ID: 2463901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology-biochemistry and physiopathology of tardive dyskinesia: review of the latest findings and controversies].
    Gómez-Galera A
    Arch Biol Med Exp; 1988 Jun; 21(1):65-9. PubMed ID: 2908731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monitoring test for the liability of neuroleptic drugs to induce tardive dyskinesia.
    Gunne LM; Bárány S
    Psychopharmacology (Berl); 1979 Jun; 63(3):195-8. PubMed ID: 39307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia?
    Waddington JL; Molloy AG
    Psychopharmacology (Berl); 1987; 91(1):136-7. PubMed ID: 2881317
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.
    Idris NF; Repeto P; Neill JC; Large CH
    Psychopharmacology (Berl); 2005 May; 179(2):336-48. PubMed ID: 15645224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Animal models of tardive dyskinesia].
    Bédard PJ; Boucher R; DiPaolo T
    Encephale; 1988 Sep; 14 Spec No():163-6. PubMed ID: 2905644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The problem of methamphetamine toxicity.
    Karch S
    West J Med; 1999 Apr; 170(4):232. PubMed ID: 10344179
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulants and neuroleptic withdrawal dyskinesia.
    Connor DF
    J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):247-8. PubMed ID: 9519625
    [No Abstract]   [Full Text] [Related]  

  • 13. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tardive akathisia and tardive dyskinesia].
    Fennig S; Helben J; Neumann M
    Harefuah; 1991 Jan; 120(2):71-2. PubMed ID: 1672523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of methamphetamine abuse in Missouri.
    Topolski JM
    Mo Med; 2007; 104(1):82-8. PubMed ID: 17410832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tardive dyskinesia in psychogeriatric patients: a five-year follow-up.
    Mehta D; Mehta S; Mathew P
    J Am Geriatr Soc; 1977 Dec; 25(12):545-7. PubMed ID: 21899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia.
    Tarsy D; Baldessarini RJ
    Annu Rev Med; 1984; 35():605-23. PubMed ID: 6144288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol.
    Gao XM; Sakai K; Tamminga CA
    Neuropsychopharmacology; 1998 Nov; 19(5):428-33. PubMed ID: 9778664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
    Shireen E; Naeem S; Inam QU; Haleem DJ
    Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.